Login Register Cart 0
Generic placeholder image

Current Cancer Therapy Reviews

Editor-in-Chief

ISSN (Print): 1573-3947
ISSN (Online): 1875-6301

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Case Report

Vagaries of the Host Response in the Development of Hepatitis B-related Hepatocellular Carcinoma: A Case Series

Author(s): Peter Block, Brianna Shinn, Christopher Roth, Laurence Needleman, Ernest Rosato and Hie-Won Hann*

Volume 16, Issue 3, 2020

Page: [253 - 258] Pages: 6

DOI: 10.2174/1573394716666200129121051

Price: $65

Abstract

The hepatitis B virus (HBV) is one of the leading causes of hepatocellular carcinoma (HCC) worldwide. In the endemic region, the infection is commonly spread through vertical transmission in which mother and child possess genetically identical viral genotypes in the setting of similar host genomes. Despite these genetic similarities, clinical outcomes from chronic hepatitis B (CHB) can vary widely, ranging from lifelong asymptomatic infection to terminal HCC. Presented here are the longitudinal observations over multiple decades of three family clusters, including monozygotic twins with non-discordant HCC, that demonstrate the heterogeneity of HBV-related outcomes. These findings emphasize the important need to untangle the role of genetic and non-genetic host factors in the development of HBV-related HCC, as well as highlight the novel research avenues that can clarify the contributions of such factors in HBV-related HCC.

Keywords: Hepatitis B virus, chronic hepatitis B, hepatocellular carcinoma, genetic host factors, immune response to hepatitis B, stress.

« Previous
Graphical Abstract

[1]
Trépo C, Chan HL, Lok A. Hepatitis B virus infection. Lancet 2014; 384(9959): 2053-63.
[http://dx.doi.org/10.1016/S0140-6736(14)60220-8] [PMID: 24954675]
[2]
McMahon BJ. The natural history of chronic hepatitis B virus infection. Hepatology 2009; 49(5)(Suppl.): S45-55.
[http://dx.doi.org/10.1002/hep.22898] [PMID: 19399792]
[3]
Obayashi A, Okochi K, Mayumi M. Familial clustering of asymptomatic carriers of Australia antigen and patients with chronic liver disease or primary liver cancer. Gastroenterology 1972; 62(4): 618-25.
[http://dx.doi.org/10.1016/S0016-5085(72)80047-7] [PMID: 5020874]
[4]
Luo X, Wang Y, Shen A, Deng H, Ye M. Relationship between the rs2596542 polymorphism in the MICA gene promoter and HBV/HCV infection-induced hepatocellular carcinoma: A meta-analysis. BMC Med Genet 2019; 20(1): 142.
[http://dx.doi.org/10.1186/s12881-019-0871-2] [PMID: 31419949]
[5]
Zheng Y, Qian Y-Y, Fan H. Pre-S2 and HBV associated hepatocellular carcinoma. Hepatoma Res 2018; 4(5): 17.
[http://dx.doi.org/10.20517/2394-5079.2018.08]
[6]
Liang TJ, Hepatitis B. Hepatitis B: the virus and disease. Hepatology 2009; 49(5)(Suppl.): S13-21.
[http://dx.doi.org/10.1002/hep.22881] [PMID: 19399811]
[7]
Hoofnagle JH, Doo E, Liang TJ, Fleischer R, Lok ASF. Management of hepatitis B: Summary of a clinical research workshop. Hepatology 2007; 45(4): 1056-75.
[http://dx.doi.org/10.1002/hep.21627] [PMID: 17393513]
[8]
An P, Xu J, Yu Y, Winkler CA. Host and viral genetic variation in HBV-related hepatocellular carcinoma. Front Genet 2018; 9(JUL): 261.
[http://dx.doi.org/10.3389/fgene.2018.00261] [PMID: 30073017]
[9]
Block TM, Guo H, Guo JT. Molecular virology of hepatitis B virus for clinicians. Clin Liver Dis 2007; 11(4): 685-706. vii
[http://dx.doi.org/10.1016/j.cld.2007.08.002] [PMID: 17981225]
[10]
Vandeven N, Nghiem P. Pathogen-driven cancers and emerging immune therapeutic strategies. Cancer Immunol Res 2014; 2(1): 9-14.
[http://dx.doi.org/10.1158/2326-6066.CIR-13-0179] [PMID: 24778160]
[11]
Akcay IM, Katrinli S, Ozdil K, Doganay GD, Doganay L. Host genetic factors affecting hepatitis B infection outcomes: Insights from genome-wide association studies. World J Gastroenterol 2018; 24(30): 3347-60.
[http://dx.doi.org/10.3748/wjg.v24.i30.3347] [PMID: 30122875]
[12]
Jiang DK, Ma XP, Yu H, et al. Genetic variants in five novel loci including CFB and CD40 predispose to chronic hepatitis B. Hepatology 2015; 62(1): 118-28.
[http://dx.doi.org/10.1002/hep.27794] [PMID: 25802187]
[13]
Kim LH, Cheong HS, Namgoong S, et al. Replication of genome wide association studies on hepatocellular carcinoma susceptibility loci of STAT4 and HLA-DQ in a Korean population. Infect Genet Evol 2015; 33: 72-6.
[http://dx.doi.org/10.1016/j.meegid.2015.04.013] [PMID: 25913043]
[14]
Lee C-H, Giuliani F. The role of inflammation in depression and fatigue. Front Immunol 2019; 10: 1696.
[http://dx.doi.org/10.3389/fimmu.2019.01696] [PMID: 31379879]
[15]
Dowlati Y, Herrmann N, Swardfager W, et al. A meta-analysis of cytokines in major depression. Biol Psychiatry 2010; 67(5): 446-57.
[http://dx.doi.org/10.1016/j.biopsych.2009.09.033] [PMID: 20015486]
[16]
Joung JY, Cho JH, Kim YH, Choi SH, Son CG. A literature review for the mechanisms of stress-induced liver injury. Brain Behav 2019; 9(3)e01235
[http://dx.doi.org/10.1002/brb3.1235] [PMID: 30761781]
[17]
Russ TC, Kivimäki M, Morling JR, Starr JM, Stamatakis E, Batty GD. Association between psychological distress and liver disease mortality: A meta-analysis of individual study participants. Gastroenterology 2015; 148(5): 958-966.e4.
[http://dx.doi.org/10.1053/j.gastro.2015.02.004] [PMID: 25680670]
[18]
Hann HW, Han SH, Block TM, et al. Symptomatology and health attitudes of chronic hepatitis B patients in the USA. J Viral Hepat 2008; 15(1): 42-51.
[PMID: 18088244]
[19]
Atesci FC, Cetin BC, Oguzhanoglu NK, Karadag F, Turgut H. Psychiatric disorders and functioning in hepatitis B virus carriers. Psychosomatics 2005; 46(2): 142-7.
[http://dx.doi.org/10.1176/appi.psy.46.2.142] [PMID: 15774953]
[20]
He Y, Gao H, Li X, Zhao Y. Psychological stress exerts effects on pathogenesis of hepatitis B via type-1/type-2 cytokines shift toward type-2 cytokine response. PLoS One 2014; 9(8)e105530
[http://dx.doi.org/10.1371/journal.pone.0105530] [PMID: 25144199]
[21]
Kunkel EJS, Kim JS, Hann H-W, et al. Depression in Korean immigrants with hepatitis B and related liver diseases. Psychosomatics 2000; 41(6): 472-80.
[http://dx.doi.org/10.1176/appi.psy.41.6.472] [PMID: 11110110]

Rights & Permissions Print Cite
Article Metrics
16
2
© 2024 Bentham Science Publishers | Privacy Policy